Publications by authors named "H Khurana"
A rod-shaped, motile, Gram-stain-positive bacterial strain RKN2, was isolated from gut of silver carp (Hypophthalmichthys molitrix) residing in Gobindsagar reservoir, Himachal Pradesh, India. Having the greatest sequence similarity to Sporosarcina koreensis F73 (98.51%), Sporosarcina luteola Y1 (98.
View Article and Find Full Text PDFArticle Synopsis
- - The study aimed to determine how preoperative pulmonary function tests (PFTs), like FEV1 and FVC, impact outcomes for patients undergoing rheumatic mitral valve surgery, addressing a lack of consensus on PFT necessity for these patients.
- - Conducted on 100 patients, the study measured pulmonary function through spirometry, along with assessing pulmonary artery pressure and blood gases, correlating the results with postoperative complications and mortality within 30 days.
- - Findings revealed that poorer pulmonary function related to increased NYHA class correlated with worse postoperative outcomes, including longer ventilation needs and higher mortality rates, highlighting the importance of evaluating PFTs in this surgical context.
Improved Arterial Stiffness Indices 3 and 6 Months after Living-donor Renal Transplantation.
Saudi J Kidney Dis Transpl
September 2023
Arterial stiffness is a non-traditional risk factor of cardiovascular disease and may explain part of the excess cardiovascular risk in chronic kidney disease patients. Successful renal transplantation (RT) may restore renal function and improve several metabolic abnormalities involved in arterial stiffness. This prospective study conducted non-invasive assessments of arterial stiffness indices [the augmentation index (AI) and pulse wave velocity (PWV)] in end-stage kidney disease (ESKD) patients before RT and 3 and 6 months after living-donor RT, alongside the effects of age and calcineurin inhibitors on arterial stiffness.
View Article and Find Full Text PDFBackground: Reactivation of hepatitis B virus (HBV) infection is a well-known risk that can occur spontaneously or following immunosuppressive therapies, including cancer chemotherapy. HBV reactivation can cause significant morbidity and even mortality, which are preventable if at-risk individuals are identified through screening and started on antiviral prophylaxis.
Aim: To determine the prevalence of chronic HBV (CHB) and occult HBV infection (OBI) among oncology and hematology-oncology patients undergoing chemotherapy.